Asset Details
Do you wish to reserve the book?
Treatment of Atrophy of the Labia Majora: Calcium Hydroxyapatite or Hyaluronic Acid?
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Treatment of Atrophy of the Labia Majora: Calcium Hydroxyapatite or Hyaluronic Acid?
Do you wish to request the book?
Treatment of Atrophy of the Labia Majora: Calcium Hydroxyapatite or Hyaluronic Acid?
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Treatment of Atrophy of the Labia Majora: Calcium Hydroxyapatite or Hyaluronic Acid?
2024
Overview
Purpose
The study aimed to evaluate and compare the efficacy and safety of treating atrophied labia majora with hyaluronic acid (HA) and calcium hydroxyapatite (CaHA).
Methods
Ten participants complaining of sagging or loss of volume in the labia majora were evaluated and randomly assigned to two groups—treated with CaHA or AH. Photographic documentation was taken and appreciated by the participants and by blind observers.
Results
The study showed an improvement in labia majora regarding volumization and flaccidity that was more significant after 90 days of treatment in both treatments. Besides flaccidity, volume replacement resulted in better balance and proportion between the labia majora and labia minora. The evaluators, independent and blind, judged that in 80% of the cases of the HA group and in 50% of cases of the CaHA group, there was an excellent improvement.
Conclusion
CaHA and HA are both effective and safe for treating the intimate region, and this study cannot prove the superiority of one over the other. An appropriate assessment involving the analysis of sagging and/or volume loss and the creation of a sequential treatment protocol, involving CaHA and HA, seems to be the best solution.
Level of Evidence I
Evidence obtained from at least one properly designed randomized controlled trial. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors
www.springer.com/00266
.
Publisher
Springer US,Springer Nature B.V
Subject
